FDA Expected To Approve Covid Treatment Pills Within Days: Paxlovid, Molnupiravir
- The Guardian, Dec. 21, 2021. - Agency will give go-ahead for Pfizer and Merck to launch groundbreaking oral treatments perhaps this week. - *Excerpts:
US federal regulators are expected to approve the first pills to treat Covid-19 as early as this week, it was reported on Tuesday. According to sources quoted by Bloomberg News, the Food and Drug Administration (FDA) will give the go-ahead for Pfizer and Merck to launch groundbreaking oral treatments perhaps as soon as Wednesday.
Amid a surge in cases caused by the Omicron virus variant, the approval of the Paxlovid (Pfizer) and molnupiravir (Merck) pills would come at a time “when we absolutely need it”, said Eric Topol, director of the Scripps Research Translational Institute, writing in the Guardian on Tuesday. “It’s a sign of light in a very long tunnel. But its extraordinary promise will not get realized unless we pull out all the stops to quickly get it made and distributed at mass scale.”
Topol told Bloomberg the unusual late-year timing of the announcement reflected the urgency of the need for the medicines.
Paxlovid performed well in clinical trials, showing almost 90% efficacy in preventing hospitalization and death in high-risk patients. Pfizer’s chief executive, Albert Bourla, said in a statement his company’s product could be “a critical tool to help quell the pandemic”. Molnupiravir has had a bumpy road towards the market. Last month the UK became the first in the world to approve the twice-daily pill, which is targeted at the elderly and those most vulnerable to severe disease. But cautious US regulators, while accepting its reduced efficacy compared with Paxlovid, sought independent analysis on the risks of birth defects and other problems in pregnant women.
An FDA advisory panel has recommended approval. Emergency use authorization this week would indicate that such concerns were reduced or eliminated.. The studies revealed that molnupiravir reduced the combined risk of hospitalisation and death by 30%. The US government has ordered 10m courses of the Pfizer pill and about 3m from Merck, Bloomberg said. But the medicines are not expected to immediately be widely available...
https://www.theguardian.com/world/2021/dec/21/fda-approve-paxlovid-molnupiravir-covid-pills
= new reply since forum marked as read
